24-Port,$29,10/100,Fast,-,Switch,/Apostolos330222.html,NETGEAR,Unmanaged,castleevents.com,(JFS524),Ethernet,Electronics , Computers Accessories , Networking Products $29 NETGEAR 24-Port Fast Ethernet 10/100 Unmanaged Switch (JFS524) - Electronics Computers Accessories Networking Products NETGEAR 24-Port Fast Industry No. 1 Ethernet 10 Unmanaged - JFS524 100 Switch 24-Port,$29,10/100,Fast,-,Switch,/Apostolos330222.html,NETGEAR,Unmanaged,castleevents.com,(JFS524),Ethernet,Electronics , Computers Accessories , Networking Products NETGEAR 24-Port Fast Industry No. 1 Ethernet 10 Unmanaged - JFS524 100 Switch $29 NETGEAR 24-Port Fast Ethernet 10/100 Unmanaged Switch (JFS524) - Electronics Computers Accessories Networking Products

NETGEAR 24-Port Fast Industry No. 1 Ethernet 10 Unmanaged - JFS524 Manufacturer direct delivery 100 Switch

NETGEAR 24-Port Fast Ethernet 10/100 Unmanaged Switch (JFS524) -

$29

NETGEAR 24-Port Fast Ethernet 10/100 Unmanaged Switch (JFS524) -

|||

Product description

Model:24port

The NETGEAR JFS524 Unmanaged Switch is designed for desktop or rackmount and features 24-Ports at 10/100Mbps Fast Ethernet, ProSAFE Lifetime Protection and more.


From the manufacturer

FS108PNA FS116NA FS116PNA JFS524 FS728TLP
# Fast Ethernet Ports 8 16 16 24 28
# SFP Fiber Ports 2 x 1G SFP (Shared)
# PoE Ports 4 x PoE 8 x PoE 12 x PoE
PoE Budget 53W 53W 100W
Management Type Unmanaged Unmanaged Unmanaged Unmanaged Smart Pro
Management Layer L2/L2+/L3 Lite
Advanced Network Features Advanced VLAN amp; QoS, IGMP, Advanced Security, Link Aggregation, IPv6
Fanless Housing ✓ ✓ ✓ ✓
Mounting Options (hardware included) Desktop or Wall Desktop or Wall Desktop or Wall Desktop or Rackmount Desktop or Rackmount
unmanaged switches smart managed plus switches smart managed pro switches smart cloud insight managed switches fully managed switches
Switch Speed 10/100M, 1G, Multi-Gig, 10G 1G, Multi-Gig, 10G 10/100M, 1G, Multi-Gig, 10G 1G 1G, Multi-Gig, 10G
Select Models with PoE ✓ ✓ ✓ ✓ ✓
Management Layer L2 L2/L2+/L3 L2+/L3 L3/L4
Web GUI Management ✓ ✓ ✓ ✓
Network Control 
(Basic VLAN, QoS, IGMP, Link Aggregation) 16-Ports and Larger ✓ ✓ ✓
Network Security 
(Storm Control, Auto DoS) ✓ ✓ ✓ ✓
Advanced VLAN amp; QoS
 (such as: MAC, Protocol, Voice, Auto-Voice, Auto-Video VLAN) ✓ ✓ ✓
Advanced Security ✓ ✓ ✓
L3 Static Routing, 
IPv6 Support Select Models ✓ ✓
Remote Monitoring and Management Through Insight App or Cloud Portal Select Models ✓

NETGEAR 24-Port Fast Ethernet 10/100 Unmanaged Switch (JFS524) -

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA